These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17598453)

  • 1. [c-Met and HGF expression in non-small-cell lung carcinomas].
    Korobko IV; Zinov'eva MV; Allakhverdiev AK; Zborovskaia IB; Svwrdlov ED
    Mol Gen Mikrobiol Virusol; 2007; (2):18-21. PubMed ID: 17598453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Suppression of WIFI transcript and protein in non-small cell lung carcinomas].
    Korobko EV; Kalinichenko SV; Shepelev MV; Zborovskaia IB; Allakhverdiev AK; Zinov'eva MV; Vinogradova TV; Sverdlov ED; Korobko IV
    Mol Gen Mikrobiol Virusol; 2007; (2):13-8. PubMed ID: 17598452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor is predominantly expressed by the carcinoma cells in non-small-cell lung cancer.
    Tsao MS; Yang Y; Marcus A; Liu N; Mou L
    Hum Pathol; 2001 Jan; 32(1):57-65. PubMed ID: 11172296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival.
    Qiao H; Hung W; Tremblay E; Wojcik J; Gui J; Ho J; Klassen J; Campling B; Elliott B
    J Cell Biochem; 2002; 86(4):665-77. PubMed ID: 12210733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA2 overexpression in non-small cell lung cancer.
    Meyer B; Loeschke S; Schultze A; Weigel T; Sandkamp M; Goldmann T; Vollmer E; Bullerdiek J
    Mol Carcinog; 2007 Jul; 46(7):503-11. PubMed ID: 17477356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
    Stabile LP; Lyker JS; Huang L; Siegfried JM
    Gene Ther; 2004 Feb; 11(3):325-35. PubMed ID: 14737093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of HGF and its receptor c-Met in renal cell carcinoma].
    Shi BB; Zhang XH; Wang HJ; Li HZ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):356-8. PubMed ID: 15312347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
    Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.
    Qian CN; Guo X; Cao B; Kort EJ; Lee CC; Chen J; Wang LM; Mai WY; Min HQ; Hong MH; Vande Woude GF; Resau JH; Teh BT
    Cancer Res; 2002 Jan; 62(2):589-96. PubMed ID: 11809714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma.
    Tokunou M; Niki T; Eguchi K; Iba S; Tsuda H; Yamada T; Matsuno Y; Kondo H; Saitoh Y; Imamura H; Hirohashi S
    Am J Pathol; 2001 Apr; 158(4):1451-63. PubMed ID: 11290563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of Met/hepatocyte growth factor receptor suppresses tumorigenicity in NCI-H1264 lung carcinoma cells.
    To C; Seiden I; Liu N; Wigle D; Tsao MS
    Exp Cell Res; 2002 Feb; 273(1):45-53. PubMed ID: 11795945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.
    Harvey P; Warn A; Newman P; Perry LJ; Ball RY; Warn RM
    J Pathol; 1996 Dec; 180(4):389-94. PubMed ID: 9014859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma.
    Kim CH; Moon SK; Bae JH; Lee JH; Han JH; Kim K; Choi EC
    Acta Otolaryngol; 2006 Jan; 126(1):88-94. PubMed ID: 16308260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoking induces overexpression of hepatocyte growth factor in type II pneumocytes and lung cancer cells.
    Chen JT; Lin TS; Chow KC; Huang HH; Chiou SH; Chiang SF; Chen HC; Chuang TL; Lin TY; Chen CY
    Am J Respir Cell Mol Biol; 2006 Mar; 34(3):264-73. PubMed ID: 16254251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of HGF, c-MET and transcription factor STAT3 in colorectal tumors.
    Trovato M; Vitarelli E; Grosso M; Alesci S; Benvenga S; Trimarchi F; Barresi G
    Eur J Histochem; 2004; 48(3):291-7. PubMed ID: 15590419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.
    Nakashiro K; Hayashi Y; Oyasu R
    Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats.
    Shimamura M; Sato N; Sata M; Wakayama K; Ogihara T; Morishita R
    Brain Res; 2007 Jun; 1151():188-94. PubMed ID: 17425951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of VEGF, c-Met and HGF/SF in secondary pleural tumors.
    Naim R; Tolnay E; Mueller KM; Kuhnen C
    Int J Mol Med; 2004 Nov; 14(5):787-91. PubMed ID: 15492846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.